Bovine serum albumin-stabilized nano-delivery system potentiates targeted anti-angiogenic therapy and synergistic photo-immunotherapy to restrict lung cancer metastasis
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide10.1002/ijc.35278 ↗
2. The evolution of non-small cell lung cancer metastases in TRACERx10.1038/s41586-023-05729-x ↗
3. Triple negative breast cancer and non-small cell lung cancer: clinical challenges and nano-formulation approaches10.1016/j.jconrel.2021.07.014 ↗
4. Relation of neovascularisation to metastasis of non-small-cell lung cancer10.1016/0140-6736(92)93217-B ↗
5. Correlation analysis among the level of IL-35, microvessel density, lymphatic vessel density, and prognosis in non-small cell lung cancer10.1111/cts.12891 ↗
6. Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability10.21037/jtd-23-1975 ↗
7. Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells10.1038/s41419-022-04594-2 ↗
8. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
9. N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy10.1016/j.actbio.2022.08.027 ↗
10. Water-dispersible MXene governs glycolysis for cancer synergistic therapy
11. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review10.1186/s12964-022-00838-y ↗
12. Monotherapy and combination therapy using anti-angiogenic nanoagents to fight cancer10.1002/adma.202005155 ↗
13. Angiogenic signaling pathways and anti-angiogenic therapy for cancer10.1038/s41392-023-01460-1 ↗
14. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond10.1002/mc.22690 ↗
15. Ávila-Moreno F: sMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-110.1038/s41417-025-00873-0 ↗
16. Unraveling the therapeutic potential of the Hedgehog pathway in cancer10.1038/nm.3389 ↗
17. Gli1 promotes epithelial–mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability10.1016/j.apsb.2022.05.024 ↗
18. Gli1-mediated tumor cell-derived bFGF promotes tumor angiogenesis and pericyte coverage in non-small cell lung cancer10.1186/s13046-024-03003-0 ↗
19. Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer10.1016/j.jconrel.2022.04.007 ↗
20. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives10.1038/s41392-021-00572-w ↗
21. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment10.1002/mco2.55 ↗
22. Two-photon phototriggering of ROS storm in ruthenium(II) coordinated carbon nitride for robust cancer immunotherapy
23. Iridium(III) photosensitizers induce simultaneous pyroptosis and ferroptosis for Multi-network synergistic tumor immunotherapy10.1002/anie.202410803 ↗
24. Plasma membrane targeted photodynamic nanoagonist to potentiate immune checkpoint blockade therapy by initiating tumor cell pyroptosis and depleting infiltrating B cells10.1002/adma.202415078 ↗
25. Mitochondrial disruption nanosystem simultaneously depressed programmed death ligand-1 and transforming growth factor-β to overcome photodynamic immunotherapy resistance10.1021/acsnano.3c10117 ↗
26. Light-activated polymeric crosslinked nanocarriers as a checkpoint blockade immunoregulatory platform for synergistic tumor therapy10.1016/j.mattod.2024.07.012 ↗
27. Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway10.1038/s41467-023-40826-5 ↗
28. Self-assembled carrier-free nanodrugs for Starvation therapy-amplified photodynamic therapy of cancer
29. Biodegradable iridium coordinated nanodrugs potentiate photodynamic therapy and immunotherapy of lung cancer10.1016/j.jcis.2024.10.156 ↗
30. A photosensitizer-inhibitor conjugate for photodynamic therapy with simultaneous inhibition of treatment escape pathways10.1016/j.biomaterials.2020.120262 ↗
31. Dual-targeting biomimetic nanomaterials for photo-/Chemo-/antiangiogenic synergistic therapy10.1021/acsami.3c03471 ↗
32. Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy10.1039/C8SC04123G ↗
33. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy10.1186/s12951-021-00952-y ↗
34. Ce6 nanoassemblies: molecular mechanism and strategies for combinational anticancer therapy10.1002/agt2.443 ↗
35. Calreticulin and cancer10.1038/s41422-020-0383-9 ↗
36. Self-delivery photo-immune stimulators for Photodynamic sensitized tumor immunotherapy10.1021/acsnano.0c06765 ↗